What is Xgeva? A Closer Look at This Bone-Modifying Drug
•
3 min read
According to the National Cancer Institute, Xgeva (denosumab) is a monoclonal antibody used to prevent or treat specific bone problems in cancer patients. It helps to reduce the risk of fractures, spinal cord compression, and other skeletal-related events.
